These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 19608688)
1. Advanced Philadelphia chromosome positive acute lymphoblastic leukemia patients relapsed after treatment with tyrosine-kinase inhibitors: successful response to clofarabine and cyclophosphamide. Vitale A; Grammatico S; Capria S; Fiocchi C; Foà R; Meloni G Haematologica; 2009 Oct; 94(10):1471-3. PubMed ID: 19608688 [No Abstract] [Full Text] [Related]
2. Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. Hijiya N; Thomson B; Isakoff MS; Silverman LB; Steinherz PG; Borowitz MJ; Kadota R; Cooper T; Shen V; Dahl G; Thottassery JV; Jeha S; Maloney K; Paul JA; Barry E; Carroll WL; Gaynon PS Blood; 2011 Dec; 118(23):6043-9. PubMed ID: 21967976 [TBL] [Abstract][Full Text] [Related]
3. [Clofarabine-based combination chemotherapy for relapse and refractory childhood acute lymphoblastic leukemia]. Arakawa Y; Koh K; Aoki T; Kubota Y; Oyama R; Mori M; Hayashi M; Hanada R Rinsho Ketsueki; 2014 Nov; 55(11):2316-9. PubMed ID: 25501414 [TBL] [Abstract][Full Text] [Related]
4. Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup. Huguet F; Leguay T; Raffoux E; Rousselot P; Vey N; Pigneux A; Ifrah N; Dombret H Leuk Lymphoma; 2015 Apr; 56(4):847-57. PubMed ID: 24996442 [TBL] [Abstract][Full Text] [Related]
5. Phase I and extension study of clofarabine plus cyclophosphamide in patients with relapsed/refractory acute lymphoblastic leukemia. Faderl S; Balakrishnan K; Thomas DA; Ravandi F; Borthakur G; Burger J; Ferrajoli A; Cortes J; O'Brien S; Kadia T; Feliu J; Plunkett W; Gandhi V; Kantarjian HM Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):231-8. PubMed ID: 24440659 [TBL] [Abstract][Full Text] [Related]
6. Clofarabine-based salvage chemotherapy for relapsed or refractory acute leukemia before allogeneic stem cell transplantation: results from a case series. Grigoleit GU; Kapp M; Tan SM; Unzicker C; Einsele H; Mielke S; Topp MS; Stuhler G Leuk Lymphoma; 2009 Dec; 50(12):2071-4. PubMed ID: 19886845 [No Abstract] [Full Text] [Related]
7. Last exit clofarabine? Faderl S Leuk Lymphoma; 2009 Dec; 50(12):1907-8. PubMed ID: 20001243 [No Abstract] [Full Text] [Related]
8. Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant. Petrungaro A; Gentile M; Mazzone C; Greco R; Uccello G; Recchia AG; De Stefano L; Bossio S; Palummo A; Morelli R; Musolino C; Morabito F; Vigna E Chemotherapy; 2017; 62(6):353-356. PubMed ID: 28810255 [TBL] [Abstract][Full Text] [Related]
9. A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias. Karp JE; Ricklis RM; Balakrishnan K; Briel J; Greer J; Gore SD; Smith BD; McDevitt MA; Carraway H; Levis MJ; Gandhi V Blood; 2007 Sep; 110(6):1762-9. PubMed ID: 17562873 [TBL] [Abstract][Full Text] [Related]
10. Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias. Zeidan AM; Ricklis RM; Carraway HE; Yun HD; Greer JM; Smith BD; Levis MJ; McDevitt MA; Pratz KW; Showel MM; Gladstone DE; Gore SD; Karp JE Br J Haematol; 2012 Jul; 158(2):198-207. PubMed ID: 22594769 [TBL] [Abstract][Full Text] [Related]
11. Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients. Miano M; Pistorio A; Putti MC; Dufour C; Messina C; Barisone E; Ziino O; Parasole R; Luciani M; Lo Nigro L; De Rossi G; Varotto S; Bertorello N; Petruzziello F; Calvillo M; Micalizzi C Leuk Lymphoma; 2012 Sep; 53(9):1693-8. PubMed ID: 22303898 [TBL] [Abstract][Full Text] [Related]
12. A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee). Nelken B; Cave H; Leverger G; Galambrun C; Plat G; Schmitt C; Thomas C; Vérité C; Brethon B; Gandemer V; Bertrand Y; Baruchel A; Rohrlich P Pediatr Blood Cancer; 2016 Feb; 63(2):270-5. PubMed ID: 26376115 [TBL] [Abstract][Full Text] [Related]
13. A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia. Hijiya N; Gaynon P; Barry E; Silverman L; Thomson B; Chu R; Cooper T; Kadota R; Rytting M; Steinherz P; Shen V; Jeha S; Abichandani R; Carroll WL Leukemia; 2009 Dec; 23(12):2259-64. PubMed ID: 19741725 [TBL] [Abstract][Full Text] [Related]
14. Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia. O'Connor D; Sibson K; Caswell M; Connor P; Cummins M; Mitchell C; Motwani J; Taj M; Vora A; Wynn R; Kearns PR Br J Haematol; 2011 Aug; 154(4):482-5. PubMed ID: 21689087 [TBL] [Abstract][Full Text] [Related]
15. Phase I dose-escalation trial of clofarabine followed by escalating doses of fractionated cyclophosphamide in children with relapsed or refractory acute leukemias. Abd Elmoneim A; Gore L; Ricklis RM; Boklan J; Cooper T; Narendran A; Rolla K; Scott T; Arceci RJ Pediatr Blood Cancer; 2012 Dec; 59(7):1252-8. PubMed ID: 22887831 [TBL] [Abstract][Full Text] [Related]
16. Refractory acute lymphoblastic leukemia in Chinese children: bridging to stem cell transplantation with clofarabine, cyclophosphamide and etoposide. Liu AP; Lee V; Li CK; Ha SY; Chiang AK Ann Hematol; 2016 Feb; 95(3):501-7. PubMed ID: 26666536 [TBL] [Abstract][Full Text] [Related]
17. Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia. Locatelli F; Testi AM; Bernardo ME; Rizzari C; Bertaina A; Merli P; Pession A; Giraldi E; Parasole R; Barberi W; Zecca M Br J Haematol; 2009 Nov; 147(3):371-8. PubMed ID: 19747360 [TBL] [Abstract][Full Text] [Related]
18. Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience. Barba P; Sampol A; Calbacho M; Gonzalez J; Serrano J; Martínez-Sánchez P; Fernández P; García-Boyero R; Bueno J; Ribera JM Am J Hematol; 2012 Jun; 87(6):631-4. PubMed ID: 22431002 [TBL] [Abstract][Full Text] [Related]
19. Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): a report from the Children's Oncology Group. Cooper TM; Razzouk BI; Gerbing R; Alonzo TA; Adlard K; Raetz E; Gamis AS; Perentesis J; Whitlock JA Pediatr Blood Cancer; 2013 Jul; 60(7):1141-7. PubMed ID: 23335239 [TBL] [Abstract][Full Text] [Related]
20. Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel protocols. Ribera JM; García O; Fernández-Abellán P; Lavilla E; Bernal MT; González-Campos J; Brunet S; Monteserín MC; Montesinos P; Sarrá J; Calbacho M; Alvarez-Larrán A; Tormo M; Oriol A; Br J Haematol; 2012 Nov; 159(4):485-8. PubMed ID: 22966847 [No Abstract] [Full Text] [Related] [Next] [New Search]